PREDICTIVE TREATMENT OF DYSGLYCEMIC EXCURSIONS ASSOCIATED WITH DIABETES MELLITUS

• US 20100291604A1
• Filed: 04/29/2010
• Published: 11/18/2010
• Est. Priority Date: 06/28/2004
• Status: Abandoned Application

• Current Assignee: Paul M. Rosman, Scott M. Pappada
• Original Assignee: Paul M. Rosman, Scott M. Pappada
• Inventors: Pappada, Scott M., Rosman, Paul M.
• Application Number:
  US12/770,378
• Publication Number:
  US 20100291604A1
• Time in Patent Office: Days
• US Class Current: 435/14
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: G01N 2800/042 Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 40/63 for local operation
• CPC Class Codes: G16H 50/50 for simulation or modelling of medical disorders
• CPC Class Codes: G16Z 99/00 Subject matter not provided for in other main groups of this subclass

Abstract

A predictive technique for treating diabetes mellitus is described whereby a patient'"'"'s blood glucose levels are monitored “continuously” over an extended period of time and a life-event diary is maintained records all significant life-events (e.g., food intake, medication, exercise, mood/emotions, etc.). This information is analyzed to derive a mathematical model that closely matches the patient'"'"'s glucose level variations for the period of monitoring. Specific daily time periods of dysglycemic vulnerability are determined by calculating when the mathematical model predicts that crossings of predetermined hyperglycemic and hypoglycemic threshold levels will occur. These predicted periods of vulnerability are then used to devise a therapeutic plan that administers treatment in anticipation of predicted dysglycemic excursions, thereby limiting the extent of those excursions or eliminating them altogether.

Claims

1. (canceled)

10. A system for predicting dysglycemic excursions in diabetes mellitus patients, comprising:

a continuous glucose monitoring system for recording a patient'"'"'s glucose levels over an extended period of time;

a life-event diary system for recording life-event information during continuous glucose monitoring; and

means for analyzing recorded glucose level information in the context of life-event information recorded by the life-event diary system to determine a model sinusoidal function that closely approximates glucose levels observed during monitoring; and

means monitoring and recording the patient'"'"'s blood glucose levels repeatedly over short intervals of time for an extended period of time of at least 72 hours to provide continuously generated glucose data with a continuous glucose monitoring system;

11. A system according to claim 10, further comprising:

means for determining anticipated glucose threshold crossing times by determining times when said model sinusoidal function crosses those threshold levels.

12. A system according to claim 11, wherein:

periods of time between said anticipated times define time windows of glycemic vulnerability.

13. A system according to claim 12, further comprising:

means for correlating recorded life-event information with corresponding fluctuations in recorded glucose levels to determine specific glycemic responses to specific life events.

14. A System according to claim 12, further comprising:

means for performing Fourier analysis of recorded continuous glucose monitoring data to determine said model sinusoidal function.

18. A system for predicting dysglycemic excursions in diabetes mellitus patients, comprising:

a continuous glucose monitoring system for recording a patient'"'"'s glucose levels over an extended period of time;

a computing device for recording life-event information during continuous glucose monitoring;

computing means for analyzing recorded glucose level information in the context of life-event information recorded by the life-event diary system to determine a model sinusoidal function that closely approximates glucose levels observed during monitoring; and

computing means for determining anticipated glucose threshold crossing times by determining times when said model sinusoidal function crosses those threshold levels.

19. A system according to claim 18, further comprising:

means for correlating recorded life-event information with corresponding fluctuations in recorded glucose levels to determine specific glycemic responses to specific life events.

20. A method for predicting time-dependent glycemic patterns in a diabetes mellitus patient, comprising:

monitoring and recording the patient'"'"'s blood glucose levels repeatedly over short intervals of time for an extended period of time of at least 72 hours to provide continuously generated glucose data with a continuous glucose monitoring system;

recording life-event data about the patient, including food intake, work stress, emotional stress, exercise, pain, gastroparesis, and sleep, arousal, and menses, for the extended period of time over which the patient'"'"'s blood glucose levels are repeatedly monitored with a programmed system for recording the life-event data;

analyzing the life-event data occurring more frequently than every 24 hours in the context of the continuously generated glucose data with the automated analysis system to define periods of vulnerability to unacceptable dysglycemic excursions of the patient when high risk life-events occur; and

identifying significant periods of dysglycemic excursion risk for the patient based upon anticipated unacceptable dysglycemic excursions of the patient based on the analysis of the identified correlations between the life-event data occurring more frequently than every 24 hours in the context of the continuously generated glucose data.

2. A method according to claim 21, further comprising:

determining anticipated times when the patient'"'"'s blood glucose levels will cross hypoglycemic and hyperglycemic threshold crossings, based upon times when said sinusoidal function crossed said threshold.

3. A method according to claim 2, further comprising:

defining windows of glycemic vulnerability during periods of time between said anticipated times.

4. A method according to claim 2, further comprising:

determining an appropriate plan of treatment based upon said anticipated times such that treatment is administered in anticipation of predicted dysglycemic episodes.

5. A method according to claim 2, further comprising:

correlating recorded life-event information with corresponding fluctuations in recorded glucose levels to determine specific glycemic responses to specific life events.

6. A method according to claim 21, further comprising:

determining said predictive sinusoidal function by Fourier analysis of recorded continuous glucose monitoring data.

7. A method according to claim 21, further comprising:

recording said life-event information in a life-event diary in electronic form by means of a computing device.

8. A method according to claim 7, wherein:

said computing device is a computer.

9. A method according to claim 8, wherein:

said computing device is a PDA (personal digital assistant).

15. A system according to claim 2, wherein:

said life-event diary system further comprises a computing device for recording said life-event information in a life-event diary in electronic form.

16. A system according to claim 6, wherein:

said computing device is a computer.

17. A system according to claim 16, wherein:

said computing device is a PDA (personal digital assistant).

21. The method according to claim 20 further including determining a predictive sinusoidal function from analyzing life-event data more frequently than every 24 hours to closely match periodic variations of blood glucose levels